TY - STD TI - Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon; 2013. Available from: http://globocan.iarc.fr. Accessed Sept 2018. UR - http://globocan.iarc.fr ID - ref1 ER - TY - JOUR AU - Silva, J. L. AU - Paulino, E. AU - Dias, M. F. AU - Melo, A. C. PY - 2015 DA - 2015// TI - Endometrial cancer: redefining the molecular-targeted approach JO - Cancer Chemother Pharmacol VL - 76 UR - https://doi.org/10.1007/s00280-015-2758-z DO - 10.1007/s00280-015-2758-z ID - Silva2015 ER - TY - JOUR AU - Sung, C. O. AU - Sohn, I. PY - 2014 DA - 2014// TI - The expression pattern of 19 genes predicts the histology of endometrial carcinoma JO - Sci Rep VL - 4 UR - https://doi.org/10.1038/srep05174 DO - 10.1038/srep05174 ID - Sung2014 ER - TY - JOUR AU - Bokhman, J. V. PY - 1983 DA - 1983// TI - Two pathogenetic types of endometrial carcinoma JO - Gynecol Oncol VL - 15 UR - https://doi.org/10.1016/0090-8258(83)90111-7 DO - 10.1016/0090-8258(83)90111-7 ID - Bokhman1983 ER - TY - JOUR AU - Gong, T. T. AU - Wang, Y. L. AU - Ma, X. X. PY - 2015 DA - 2015// TI - Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep14051 DO - 10.1038/srep14051 ID - Gong2015 ER - TY - JOUR AU - Amant, F. AU - Moerman, P. AU - Neven, P. AU - Timmerman, D. AU - Limbergen, E. AU - Vergote, I. PY - 2005 DA - 2005// TI - Endometrial cancer JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67063-8 DO - 10.1016/S0140-6736(05)67063-8 ID - Amant2005 ER - TY - JOUR AU - Trope, C. AU - Johnsson, J. E. AU - Simonsen, E. AU - Christiansen, H. AU - Cavallin-Stahl, E. AU - Horvath, G. PY - 1984 DA - 1984// TI - Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin JO - Am J Obstet Gynecol VL - 149 UR - https://doi.org/10.1016/0002-9378(84)90147-9 DO - 10.1016/0002-9378(84)90147-9 ID - Trope1984 ER - TY - JOUR AU - Temkin, S. M. AU - Fleming, G. PY - 2009 DA - 2009// TI - Current treatment of metastatic endometrial cancer JO - Cancer Control VL - 16 UR - https://doi.org/10.1177/107327480901600106 DO - 10.1177/107327480901600106 ID - Temkin2009 ER - TY - JOUR AU - Kauppila, A. n. t. t. i. PY - 1984 DA - 1984// TI - Progestin Therapy of Endometrial, Breast and Ovarian Carcinoma: A review of clinical observations JO - Acta Obstetricia et Gynecologica Scandinavica VL - 63 UR - https://doi.org/10.3109/00016348409156700 DO - 10.3109/00016348409156700 ID - Kauppila1984 ER - TY - JOUR AU - Sievers, E. L. AU - Larson, R. A. AU - Stadtmauer, E. A. AU - Estey, E. AU - Lowenberg, B. AU - Dombret, H. PY - 2001 DA - 2001// TI - Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.13.3244 DO - 10.1200/JCO.2001.19.13.3244 ID - Sievers2001 ER - TY - JOUR AU - Senter, P. D. AU - Sievers, E. L. PY - 2012 DA - 2012// TI - The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma JO - Nat Biotechnol VL - 30 UR - https://doi.org/10.1038/nbt.2289 DO - 10.1038/nbt.2289 ID - Senter2012 ER - TY - JOUR AU - Verma, S. AU - Miles, D. AU - Gianni, L. AU - Krop, I. E. AU - Welslau, M. AU - Baselga, J. PY - 2012 DA - 2012// TI - Trastuzumab emtansine for HER2-positive advanced breast cancer JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1209124 DO - 10.1056/NEJMoa1209124 ID - Verma2012 ER - TY - JOUR AU - Lamb, Y. N. PY - 2017 DA - 2017// TI - Inotuzumab Ozogamicin: First Global Approval JO - Drugs VL - 77 UR - https://doi.org/10.1007/s40265-017-0802-5 DO - 10.1007/s40265-017-0802-5 ID - Lamb2017 ER - TY - STD TI - Gonzalez D, Conlan RS. Therapeutic agents and use thereof. The United States Patent and Trademark Office. United States; 2015. ID - ref14 ER - TY - JOUR AU - Liliensiek, B. AU - Weigand, M. A. AU - Bierhaus, A. AU - Nicklas, W. AU - Kasper, M. AU - Hofer, S. PY - 2004 DA - 2004// TI - Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response JO - J Clin Invest VL - 113 UR - https://doi.org/10.1172/JCI200418704 DO - 10.1172/JCI200418704 ID - Liliensiek2004 ER - TY - JOUR AU - Gefter, J. V. AU - Shaufl, A. L. AU - Fink, M. P. AU - Delude, R. L. PY - 2009 DA - 2009// TI - Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines JO - Cell Tissue Res VL - 337 UR - https://doi.org/10.1007/s00441-009-0791-0 DO - 10.1007/s00441-009-0791-0 ID - Gefter2009 ER - TY - JOUR AU - Hofer, S. AU - Uhle, F. AU - Fleming, T. AU - Hell, C. AU - Schmoch, T. AU - Bruckner, T. PY - 2016 DA - 2016// TI - RAGE-mediated inflammation in patients with septic shock JO - J Surg Res VL - 202 UR - https://doi.org/10.1016/j.jss.2016.01.019 DO - 10.1016/j.jss.2016.01.019 ID - Hofer2016 ER - TY - JOUR AU - Gebhardt, C. AU - Riehl, A. AU - Durchdewald, M. AU - Nemeth, J. AU - Furstenberger, G. AU - Muller-Decker, K. PY - 2008 DA - 2008// TI - RAGE signaling sustains inflammation and promotes tumor development JO - J Exp Med VL - 205 UR - https://doi.org/10.1084/jem.20070679 DO - 10.1084/jem.20070679 ID - Gebhardt2008 ER - TY - JOUR AU - Taguchi, A. AU - Blood, D. C. AU - Toro, G. AU - Canet, A. AU - Lee, D. C. AU - Qu, W. PY - 2000 DA - 2000// TI - Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases JO - Nature VL - 405 UR - https://doi.org/10.1038/35012626 DO - 10.1038/35012626 ID - Taguchi2000 ER - TY - JOUR AU - Hiwatashi, K. AU - Ueno, S. AU - Abeyama, K. AU - Kubo, F. AU - Sakoda, M. AU - Maruyama, I. PY - 2008 DA - 2008// TI - A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC JO - Ann Surg Oncol VL - 15 UR - https://doi.org/10.1245/s10434-007-9698-8 DO - 10.1245/s10434-007-9698-8 ID - Hiwatashi2008 ER - TY - JOUR AU - Köhler, G. AU - Milstein, C. PY - 1976 DA - 1976// TI - Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion JO - Eur J Immunol VL - 6 UR - https://doi.org/10.1002/eji.1830060713 DO - 10.1002/eji.1830060713 ID - Köhler1976 ER - TY - JOUR AU - Margarit, L. AU - Taylor, A. AU - Roberts, M. H. AU - Hopkins, L. AU - Davies, C. AU - Brenton, A. G. PY - 2010 DA - 2010// TI - MUC1 as a discriminator between endometrium from fertile and infertile patients with PCOS and endometriosis JO - J Clin Endocrinol Metab VL - 95 UR - https://doi.org/10.1210/jc.2010-0603 DO - 10.1210/jc.2010-0603 ID - Margarit2010 ER - TY - JOUR AU - Healey, G. a. r. e. t. h. D. AU - Frostell, A. s. a. AU - Fagge, T. i. m. AU - Gonzalez, D. e. y. a. r. i. n. a. AU - Conlan, R. S. t. e. v. e. n. PY - 2019 DA - 2019// TI - A RAGE-Targeted Antibody-Drug Conjugate: Surface Plasmon Resonance as a Platform for Accelerating Effective ADC Design and Development JO - Antibodies VL - 8 UR - https://doi.org/10.3390/antib8010007 DO - 10.3390/antib8010007 ID - Healey2019 ER - TY - JOUR AU - Nath, N. AU - Godat, B. AU - Zimprich, C. AU - Dwight, S. J. AU - Corona, C. AU - McDougall, M. PY - 2016 DA - 2016// TI - Homogeneous plate based antibody internalization assay using pH sensor fluorescent dye JO - J Immunol Methods VL - 431 UR - https://doi.org/10.1016/j.jim.2016.02.001 DO - 10.1016/j.jim.2016.02.001 ID - Nath2016 ER - TY - JOUR AU - Costes, S. V. AU - Daelemans, D. AU - Cho, E. H. AU - Dobbin, Z. AU - Pavlakis, G. AU - Lockett, S. PY - 2004 DA - 2004// TI - Automatic and quantitative measurement of protein-protein\nColocalization in live cells JO - Biophys J VL - 86 UR - https://doi.org/10.1529/biophysj.103.038422 DO - 10.1529/biophysj.103.038422 ID - Costes2004 ER - TY - JOUR AU - Dunn, K. W. AU - Kamocka, M. M. AU - McDonald, J. H. PY - 2011 DA - 2011// TI - A practical guide to evaluating colocalization in biological microscopy JO - AJP Cell Physiol VL - 300 UR - https://doi.org/10.1152/ajpcell.00462.2010 DO - 10.1152/ajpcell.00462.2010 ID - Dunn2011 ER - TY - JOUR AU - Srinivasan, R. AU - Benton, E. AU - McCormick, F. AU - Thomas, H. AU - Gullick, W. J. PY - 1999 DA - 1999// TI - Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer JO - Clin Cancer Res VL - 5 ID - Srinivasan1999 ER - TY - JOUR AU - Hetzel, D. J. AU - Keeney, G. L. AU - Roche, P. C. AU - Cha, S. S. AU - Podratz, K. C. PY - 1992 DA - 1992// TI - HER-2/neu expression: a major prognostic factor in endometrial cancer JO - Gynecol Oncol VL - 47 UR - https://doi.org/10.1016/0090-8258(92)90103-P DO - 10.1016/0090-8258(92)90103-P ID - Hetzel1992 ER - TY - JOUR AU - Acharya, S. AU - Hensley, M. L. AU - Montag, A. C. AU - Fleming, G. F. PY - 2005 DA - 2005// TI - Rare uterine cancers JO - Lancet Oncol VL - 6 UR - https://doi.org/10.1016/S1470-2045(05)70463-0 DO - 10.1016/S1470-2045(05)70463-0 ID - Acharya2005 ER - TY - JOUR AU - Konecny, G. E. AU - Venkatesan, N. AU - Yang, G. AU - Dering, J. AU - Ginther, C. AU - Finn, R. PY - 2008 DA - 2008// TI - Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells JO - Br J Cancer VL - 98 UR - https://doi.org/10.1038/sj.bjc.6604278 DO - 10.1038/sj.bjc.6604278 ID - Konecny2008 ER - TY - JOUR AU - Moxley, K. M. AU - McMeekin, D. S. PY - 2010 DA - 2010// TI - Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents JO - Oncologist VL - 15 UR - https://doi.org/10.1634/theoncologist.2010-0087 DO - 10.1634/theoncologist.2010-0087 ID - Moxley2010 ER - TY - JOUR AU - Malik, P. AU - Chaudhry, N. AU - Mittal, R. AU - Mukherjee, T. K. PY - 2015 DA - 2015// TI - Role of receptor for advanced glycation end products in the complication and progression of various types of cancers JO - Biochim Biophys Acta VL - 1850 UR - https://doi.org/10.1016/j.bbagen.2015.05.020 DO - 10.1016/j.bbagen.2015.05.020 ID - Malik2015 ER - TY - JOUR AU - Kang, R. AU - Loux, T. AU - Tang, D. AU - Schapiro, N. E. AU - Vernon, P. AU - Livesey, K. M. PY - 2012 DA - 2012// TI - The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1113865109 DO - 10.1073/pnas.1113865109 ID - Kang2012 ER - TY - JOUR AU - Kuniyasu, H. AU - Oue, N. AU - Wakikawa, A. AU - Shigeishi, H. AU - Matsutani, N. AU - Kuraoka, K. PY - 2002 DA - 2002// TI - Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1031 DO - 10.1002/path.1031 ID - Kuniyasu2002 ER - TY - JOUR AU - Zhang, S. AU - Hou, X. AU - Zi, S. AU - Wang, Y. AU - Chen, L. AU - Kong, B. PY - 2013 DA - 2013// TI - Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients JO - Cell Physiol Biochem VL - 31 UR - https://doi.org/10.1159/000350073 DO - 10.1159/000350073 ID - Zhang2013 ER - TY - JOUR AU - Uetz-Von Allmen, E. AU - Koch, M. AU - Fritz, G. AU - Legler, D. F. PY - 2008 DA - 2008// TI - V domain of RAGE interacts with AGEs on prostate carcinoma cells JO - Prostate VL - 68 UR - https://doi.org/10.1002/pros.20736 DO - 10.1002/pros.20736 ID - Uetz-Von Allmen2008 ER - TY - JOUR AU - Lertwittayapon, T. AU - Tencomnao, T. AU - Santiyanont, R. PY - 2012 DA - 2012// TI - Inhibitory effect of alternatively spliced RAGEv1 on the expression of NF-κB and TNF-α in hepatocellular carcinoma cells JO - Genet Mol Res VL - 11 UR - https://doi.org/10.4238/2012.June.29.3 DO - 10.4238/2012.June.29.3 ID - Lertwittayapon2012 ER - TY - JOUR AU - Poljicanin, A. AU - Filipovic, N. AU - Vukusic Pusic, T. AU - Soljic, V. AU - Caric, A. AU - Saraga-Babic, M. PY - 2015 DA - 2015// TI - Expression pattern of RAGE and IGF-1 in the human fetal ovary and ovarian serous carcinoma JO - Acta Histochem VL - 117 UR - https://doi.org/10.1016/j.acthis.2015.01.004 DO - 10.1016/j.acthis.2015.01.004 ID - Poljicanin2015 ER - TY - STD TI - Nasser MW, Ahirwar DK, Ganju RK. RAGE: A novel target for breast cancer growth and metastasis. Oncoscience. 2016. ID - ref39 ER - TY - JOUR AU - Logsdon, C. D. AU - Fuentes, M. K. AU - Huang, E. H. AU - Arumugam, T. PY - 2007 DA - 2007// TI - RAGE and RAGE ligands in cancer JO - Curr Mol Med VL - 7 UR - https://doi.org/10.2174/156652407783220697 DO - 10.2174/156652407783220697 ID - Logsdon2007 ER - TY - JOUR AU - Lata, K. AU - Mukherjee, T. K. PY - 2014 DA - 2014// TI - Knockdown of receptor for advanced glycation end products attenuate 17α-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells JO - Biochim Biophys Acta VL - 1840 UR - https://doi.org/10.1016/j.bbagen.2013.11.014 DO - 10.1016/j.bbagen.2013.11.014 ID - Lata2014 ER - TY - JOUR AU - Lutterloh, E. C. AU - Opal, S. M. AU - Pittman, D. D. AU - Keith, J. C. AU - Tan, X. -. Y. AU - Clancy, B. M. PY - 2007 DA - 2007// TI - Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc6184 DO - 10.1186/cc6184 ID - Lutterloh2007 ER - TY - JOUR AU - Kuhla, A. AU - Norden, J. AU - Abshagen, K. AU - Menger, M. D. AU - Vollmar, B. PY - 2013 DA - 2013// TI - RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure JO - Br J Surg VL - 100 UR - https://doi.org/10.1002/bjs.9188 DO - 10.1002/bjs.9188 ID - Kuhla2013 ER - TY - JOUR AU - Vriese, A. S. AU - Flyvbjerg, A. AU - Mortier, S. AU - Tilton, R. G. AU - Lameire, N. H. PY - 2003 DA - 2003// TI - Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane JO - J Am Soc Nephrol VL - 14 ID - Vriese2003 ER - TY - JOUR AU - Abe, R. AU - Shimizu, T. AU - Sugawara, H. AU - Watanabe, H. AU - Nakamura, H. AU - Choei, H. PY - 2004 DA - 2004// TI - Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions JO - J Invest Dermatol VL - 122 UR - https://doi.org/10.1046/j.0022-202X.2004.22218.x DO - 10.1046/j.0022-202X.2004.22218.x ID - Abe2004 ER - TY - JOUR AU - Santin, A. D. AU - Bellone, S. AU - Stedum, S. AU - Bushen, W. AU - Las Casas, L. E. AU - Korourian, S. PY - 2005 DA - 2005// TI - Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization JO - Gynecol Oncol VL - 98 UR - https://doi.org/10.1016/j.ygyno.2005.03.041 DO - 10.1016/j.ygyno.2005.03.041 ID - Santin2005 ER - TY - JOUR AU - Perez, H. L. AU - Cardarelli, P. M. AU - Deshpande, S. AU - Gangwar, S. AU - Schroeder, G. M. AU - Vite, G. D. PY - 2014 DA - 2014// TI - Antibody-drug conjugates: current status and future directions JO - Drug Discov Today VL - 19 UR - https://doi.org/10.1016/j.drudis.2013.11.004 DO - 10.1016/j.drudis.2013.11.004 ID - Perez2014 ER - TY - JOUR AU - Koch, M. AU - Chitayat, S. AU - Dattilo, B. M. AU - Schiefner, A. AU - Diez, J. AU - Chazin, W. J. PY - 2010 DA - 2010// TI - Structural basis for ligand recognition and activation of RAGE JO - Structure VL - 18 UR - https://doi.org/10.1016/j.str.2010.05.017 DO - 10.1016/j.str.2010.05.017 ID - Koch2010 ER - TY - JOUR AU - Dattilo, B. M. AU - Fritz, G. AU - Leclerc, E. AU - Kooi, C. W. AU - Heizmann, C. W. AU - Chazin, W. J. PY - 2007 DA - 2007// TI - The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units JO - Biochemistry VL - 46 UR - https://doi.org/10.1021/bi7003735 DO - 10.1021/bi7003735 ID - Dattilo2007 ER - TY - JOUR AU - Leclerc, E. AU - Fritz, G. AU - Weibel, M. AU - Heizmann, C. W. AU - Galichet, A. PY - 2007 DA - 2007// TI - S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M703951200 DO - 10.1074/jbc.M703951200 ID - Leclerc2007 ER - TY - JOUR AU - Rai, V. AU - Toure, F. AU - Chitayat, S. AU - Pei, R. AU - Song, F. AU - Li, Q. PY - 2012 DA - 2012// TI - Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling JO - J Exp Med VL - 209 UR - https://doi.org/10.1084/jem.20120873 DO - 10.1084/jem.20120873 ID - Rai2012 ER - TY - JOUR AU - Kierdorf, K. AU - Fritz, G. PY - 2013 DA - 2013// TI - RAGE regulation and signaling in inflammation and beyond JO - J Leukoc Biol VL - 94 UR - https://doi.org/10.1189/jlb.1012519 DO - 10.1189/jlb.1012519 ID - Kierdorf2013 ER - TY - JOUR AU - Hsieh, H. L. AU - Schafer, B. W. AU - Weigle, B. AU - Heizmann, C. W. PY - 2004 DA - 2004// TI - S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells JO - Biochem Biophys Res Commun VL - 316 UR - https://doi.org/10.1016/j.bbrc.2004.02.135 DO - 10.1016/j.bbrc.2004.02.135 ID - Hsieh2004 ER - TY - JOUR AU - Marinakis, E. AU - Bagkos, G. AU - Piperi, C. AU - Roussou, P. AU - Diamanti-Kandarakis, E. PY - 2014 DA - 2014// TI - Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention? JO - Clin Chem Lab Med VL - 52 UR - https://doi.org/10.1515/cclm-2013-0578 DO - 10.1515/cclm-2013-0578 ID - Marinakis2014 ER - TY - JOUR AU - Sparvero, L. J. AU - Asafu-Adjei, D. AU - Kang, R. AU - Tang, D. AU - Amin, N. AU - Im, J. PY - 2009 DA - 2009// TI - RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation JO - J Transl Med VL - 7 UR - https://doi.org/10.1186/1479-5876-7-17 DO - 10.1186/1479-5876-7-17 ID - Sparvero2009 ER - TY - JOUR AU - Li, J. Y. AU - Perry, S. R. AU - Muniz-Medina, V. AU - Wang, X. AU - Wetzel, L. K. AU - Rebelatto, M. C. PY - 2016 DA - 2016// TI - A biparatopic HER2-targeting antibody-drug conjugate induces tumor regression in primary models refractory to or ineligible for HER2-Targeted therapy JO - Cancer Cell VL - 29 UR - https://doi.org/10.1016/j.ccell.2015.12.008 DO - 10.1016/j.ccell.2015.12.008 ID - Li2016 ER - TY - JOUR AU - Deslandes, A. PY - 2014 DA - 2014// TI - Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human phase 1 studies JO - MAbs VL - 6 UR - https://doi.org/10.4161/mabs.28965 DO - 10.4161/mabs.28965 ID - Deslandes2014 ER -